NeuroSense Therapeutics (NRSN) Non Operating Income (2022 - 2024)
NeuroSense Therapeutics' (NRSN) quarterly Non Operating Income came in at -$30000.0 in Q4 2024, up 76.0% year-over-year from -$17045.5 in Q1 2024, and up 26.83% quarter-over-quarter from -$41000.0 in Q3 2024.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Non Operating Income (2022 - 2024) Analysis & Trends
NeuroSense Therapeutics has disclosed Non Operating Income across 3 years of filings, most recently posting -$30000.0 for Q4 2024.
- In Q4 2024, Non Operating Income rose 76.0% year-over-year to -$30000.0; the TTM figure through Dec 2024 stood at -$308000.0 (down 115.86% YoY), while the FY2025 annual figure was -$40000.0, up 87.01% from the prior year.
- Non Operating Income came in at -$30000.0 for Q4 2024 at NeuroSense Therapeutics, up from -$41000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $2.2 million in Q2 2024 to a low of -$2.4 million in Q1 2024.
- Average Non Operating Income over 3 years is $169900.0, with a median of $18500.0 recorded in 2023.
- The largest YoY upside for Non Operating Income was 417.38% in 2024 against a maximum downside of 3697.01% in 2024.
- Over 3 years, Non Operating Income stood at -$484000.0 in 2022, then jumped by 74.17% to -$125000.0 in 2023, then jumped by 76.0% to -$30000.0 in 2024.
- Per Business Quant data, the three most recent Non Operating Income figures were -$30000.0 in Q4 2024, -$41000.0 in Q3 2024, and $2.2 million in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | -73.00 Mn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 387.00 Mn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 234.30 Mn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | - |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | - |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | -53.64 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | - |
| 10 | NeuroSense Therapeutics | 8.09 Mn | 7.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -30,000.00 |
| Sep 30, 2024 | -41,000.00 |
| Jun 30, 2024 | 2.17 Mn |
| Mar 31, 2024 | -2.41 Mn |
| Dec 31, 2023 | -125,000.00 |
| Sep 30, 2023 | 1.58 Mn |
| Jun 30, 2023 | 420,000.00 |
| Mar 31, 2023 | 67,000.00 |
| Jun 30, 2022 | -484,000.00 |
| Mar 31, 2022 | 549,000.00 |
API Access
NeuroSense Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();